HK1204773A1 - 吡唑衍生物及其醫藥用途 - Google Patents

吡唑衍生物及其醫藥用途

Info

Publication number
HK1204773A1
HK1204773A1 HK15105374.8A HK15105374A HK1204773A1 HK 1204773 A1 HK1204773 A1 HK 1204773A1 HK 15105374 A HK15105374 A HK 15105374A HK 1204773 A1 HK1204773 A1 HK 1204773A1
Authority
HK
Hong Kong
Prior art keywords
medical purposes
pyrazole derivative
pyrazole
derivative
medical
Prior art date
Application number
HK15105374.8A
Other languages
English (en)
Inventor
Masayuki Isaji
Masaaki Takemura
Hidetoshi Isawa
Yukihiko Hotei
Itaru Miyashita
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of HK1204773A1 publication Critical patent/HK1204773A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15105374.8A 2012-05-07 2015-06-05 吡唑衍生物及其醫藥用途 HK1204773A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012105847 2012-05-07
PCT/JP2013/062755 WO2013168671A1 (ja) 2012-05-07 2013-05-02 ピラゾール誘導体及びその医薬用途

Publications (1)

Publication Number Publication Date
HK1204773A1 true HK1204773A1 (zh) 2015-12-04

Family

ID=49550709

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105374.8A HK1204773A1 (zh) 2012-05-07 2015-06-05 吡唑衍生物及其醫藥用途

Country Status (16)

Country Link
US (2) US9273085B2 (zh)
EP (1) EP2848254B1 (zh)
JP (2) JP5663699B2 (zh)
KR (1) KR101868991B1 (zh)
CN (1) CN104284665B (zh)
AU (1) AU2013258566B2 (zh)
BR (1) BR112014027841B1 (zh)
CA (1) CA2872002C (zh)
DK (1) DK2848254T3 (zh)
ES (1) ES2601127T3 (zh)
HK (1) HK1204773A1 (zh)
MX (1) MX359988B (zh)
PL (1) PL2848254T3 (zh)
PT (1) PT2848254T (zh)
RU (1) RU2602739C2 (zh)
WO (1) WO2013168671A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS60901B1 (sr) 2010-11-08 2020-11-30 Albireo Ab Ibat inhibitori za lečenje oboljenja jetre
ES2601127T3 (es) * 2012-05-07 2017-02-14 Kissei Pharmaceutical Co., Ltd. Derivado de pirazol y su uso con fines médicos
US10022389B2 (en) 2013-02-04 2018-07-17 Taisho Pharmaceutical Co., Ltd. Prophylactic or therapeutic drug for constipation
CA2952405A1 (en) * 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Solid formulation and method for stabilizing the same
CA2952406A1 (en) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Solid formulation and method for preventing or reducing coloration thereof
MX2020009349A (es) 2018-03-28 2021-04-28 Avolynt Método para el tratamiento de la hipoglucemia posprandial.
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
CA3100691A1 (en) 2018-06-20 2019-12-26 Albireo Ab Crystal modifications of odevixibat
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
EP4069247A1 (en) 2019-12-04 2022-10-12 Albireo AB Benzothiadiazepine compounds and their use as bile acid modulators
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
JP2023504645A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2023537285A (ja) 2020-08-03 2023-08-31 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
EP4243831A1 (en) 2020-11-12 2023-09-20 Albireo AB Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
JP2024500309A (ja) 2020-12-04 2024-01-09 アルビレオ エービー ベンゾチア(ジ)アゼピン化合物および胆汁酸モジュレータとしてのその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
KR101402474B1 (ko) * 2006-04-26 2014-06-19 제넨테크, 인크. 포스포이노시티드 3-키나제 억제제 화합물 및 이를 포함하는 약학적 조성물
RU2482122C2 (ru) * 2007-12-27 2013-05-20 Киссеи Фармасьютикал Ко., Лтд. Моносебацинат производного пиразола
CA2725230C (en) 2008-04-16 2016-05-17 Kissei Pharmaceutical Co., Ltd. Hemifumarate of a pyrazole derivative
AR087701A1 (es) 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
ES2601127T3 (es) * 2012-05-07 2017-02-14 Kissei Pharmaceutical Co., Ltd. Derivado de pirazol y su uso con fines médicos

Also Published As

Publication number Publication date
US9273085B2 (en) 2016-03-01
EP2848254B1 (en) 2016-08-03
CA2872002C (en) 2019-01-15
DK2848254T3 (en) 2016-10-31
US20150141631A1 (en) 2015-05-21
RU2602739C2 (ru) 2016-11-20
CA2872002A1 (en) 2013-11-14
JPWO2013168671A1 (ja) 2016-01-07
EP2848254A4 (en) 2015-07-15
WO2013168671A1 (ja) 2013-11-14
CN104284665B (zh) 2016-11-16
PL2848254T3 (pl) 2017-03-31
BR112014027841A2 (pt) 2017-06-27
AU2013258566A1 (en) 2014-11-27
BR112014027841B1 (pt) 2022-08-09
BR112014027841A8 (pt) 2021-09-28
PT2848254T (pt) 2016-10-05
RU2014149181A (ru) 2016-06-27
JP5663699B2 (ja) 2015-02-04
ES2601127T3 (es) 2017-02-14
US20160129031A1 (en) 2016-05-12
KR20150013671A (ko) 2015-02-05
MX2014013696A (es) 2015-02-05
JP2015083580A (ja) 2015-04-30
EP2848254A1 (en) 2015-03-18
KR101868991B1 (ko) 2018-06-19
US9694027B2 (en) 2017-07-04
CN104284665A (zh) 2015-01-14
AU2013258566B2 (en) 2017-03-16
MX359988B (es) 2018-10-18
JP6105546B2 (ja) 2017-03-29

Similar Documents

Publication Publication Date Title
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
HK1204773A1 (zh) 吡唑衍生物及其醫藥用途
HK1204253A1 (zh) 醫用磁強計
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
HK1202290A1 (zh) 吡唑化合物和其醫藥用途
EP2842945A4 (en) SULFONAMIDE DERIVATIVE AND MEDICAL USE THEREOF
EP2740728A4 (en) URACIL DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
EP2832724A4 (en) NIPETIC ACID DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
PT2656843E (pt) Ésteres de bendamustina e compostos relacionados e a sua utilização médica
GB201215502D0 (en) Medical use
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
GB2502895B (en) Trouser Braces and Adaptor
GB201216381D0 (en) New compounds and medical uses
GB201208970D0 (en) New compounds and medical uses
HUE043268T2 (hu) Pirazolvegyületek és azok gyógyászati alkalmazása